Method for separation and purification of hydrocodone by preparative chromatography
View Patent ↗A process for the purification of an impure preparation containing hydrocodone by means of a reverse phase preparative chromatography process is provided. In an illustrative embodiment a chromatographic column is loaded with a stationary phase, typically a silica particle having an organic ligand bound thereto. The impure preparation is acidified and passed through the column with a loading ratio of from about 10 to about 1000. The column is eluted, typically with an aqueous solution of acetonitrile, and the purified hydrocodone is obtained in a specified fraction.
1. A process for recovering hydrocodone from a hydrocodone preparation, the process comprising subjecting the hydrocodone preparation to reverse-phase liquid chromatography wherein the loading ratio of a stationary phase to hydrocodone is not more than about 1000, and wherein the hydrocodone recovered is at least about 95% pure.
2. A process for recovering hydrocodone from a hydrocodone preparation which comprises subjecting the hydrocodone preparation to a reverse-phase high performance preparative liquid chromatography and recovering hydrocodone.
3. The process of claim 1 wherein the loading ratio is in the range of about 10 to about 1000.
4. The process of claim 1 wherein the loading ratio is in the range of about 20 to about 40.
5. The process of claim 1 wherein the stationary phase is selected from the group consisting of alkylsilanes, arylsilanes, haloalkylsilanes, alkyl esters, aryl esters, alkyl amines, alkylcyano compounds, alkyldiols, alkyl ethers, aryl ethers, haloalkyl ethers, alkylcarboxylic acids, arylcarboxylic acids, alkysulfonic acids, arylsulfonic acids, polystyrenedivinylbenzene, aminopolycaprolactam and glvcidoxyethylmethoxysilane.
6. The process of claim 1 wherein the stationary phase is a bonded-phase silica containing ligands selected from the group consisting of butyl-, octyl-, octadecyl-, tricosane-, cyano- and phenyl-moieties.
7. The process of claim 6 wherein the ligand is octadecyl-silane.
8. The process of claim 1 wherein a chromatography column is eluted with a mobile phase comprising an aqueous acidic solution containing an organic solvent.
9. The process of claim 8 wherein the acid employed to acidify the aqueous acidic solution is selected from the group consisting of acetic, malic, tartaric, sulfuric, formic, oxalic, lactic, hydrochloric, hydrobromic, phosphoric, phosphorous, and nitric.
10. The process of claim 8 wherein the aqueous mobile phase pH is in the range of from about 1 to about 7.
11. The process of claim 10 wherein the pH is in the range of from about 2 to about 3.
12. The process of claim 8 wherein the organic solvent is an alcohol.
13. The process of claim 12 wherein the alcohol is selected from the group consisting of methanol, propanol, isopropanol, butanol and t-butanol.
14. The process of claim 8 wherein the organic solvent is acetonitrile.
15. The process of claim 1 wherein the hydrocodone preparation is acidified so as to prepare a hydrocodone salt.
16. The process of claim 15 wherein the acid employed to acidify the hydrocodone preparation is an inorganic acid.
17. The process of claim 16 wherein the inorganic acid is selected from the group consisting of, sulfuric acid hydrochloric acid, hydrobromic acid, phosphoric acid, phosphorous acid, and nitric acid.
18. The process of claim 15 wherein the acid employed to acidify the hydrocodone preparation is an organic acid.
19. The process of claim 18 wherein the organic acid is selected from the group consisting of acetic acid, malic acid, tartaric acid, formic acid, oxalic acid, and lactic acid.
20. The process of claim 15 wherein the pH of the hydrocodone preparation is in the range of from about 1 to about 7.
21. The process of claim 20 wherein the pH of the hydrocodone preparation is in the range of about from about 2 to about 3.
22. The process of claim 17 wherein the organic acid is tartaric acid.
23. The process of claim 14 wherein the acetonitrile is in the range of from about 5 to about 100 volume percent.
24. The process of claim 14 where the acetonitrile is in the range of from about 2 to about 20 volume percent during the collection of the purified hydrocodone.
25. A process for purifying a hydrocodone preparation containing an α,β unsaturated ketone, the process comprising the steps of
(a) packing a chromatographic column with a reverse-phase chromatographic packing material;
(b) passing through said column an aqueous, acidified solution of hydrocodone preparation at a loading ratio of from about 10 to about 1000 and
(c) eluting said column with an aqueous solution of an organic solvent to produce an eluate containing hydrocodone having less than about 10 ppm α,β unsaturated ketone.
26. The process of claim 25 wherein the eluate is divided into four fractions wherein:
(i.) a first fraction is discarded,
(ii.) a second fraction that is combined with a fourth fraction wherein the water and organic solvent are substantially reduced and then recycled through the column, and
(iii.) a third fractions that contains less than about 10 ppm α,β unsaturated ketone.
27. The process of claim 1 , wherein the reverse-phase liquid chromatography comprises a reverse-phase high performance preparative liquid chromatography.
28. The process of claim 7 , wherein a chromatography column containing the stationary phase is eluted with a mobile phase comprising an aqueous acidic solution containing acetonitrile.